Epstein Secrets

ion and therefore did not render invalid, in whole or in part, electronic surveillance and physical search authorized by the court." Politico (8/3, Gerstein, 4.29M) reports, "A review by the Justice Department and FBI of their practices for seeking approval of intelligence-related surveillance found that

l purposes." The Washington Examiner (8/3, Leonardi, 448K), the Washington Times (8/3, Mordock, 492K), The Hill (8/3, Neidig, 2.98M), Politico (8/3, Gerstein, 4.29M), Reuters (8/3, Freifeld), and Bloomberg (8/3, Van Voris, 4.73M), among other news outlets, also cover Monday's court filings. Trump: Effor

RN- TVVi Nashville, TN (8/3, 24K), and WXIA-TVVI Atlanta (8/3, 100K). Monoclonal Antibodies Could Be "Next Big Advance" In Treatment. Reuters (8/3, Beasley) reports, "As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

ion and therefore did not render invalid, in whole or in part, electronic surveillance and physical search authorized by the court." Politico (8/3, Gerstein, 4.29M) reports, "A review by the Justice Department and FBI of their practices for seeking approval of intelligence-related surveillance found that

l purposes." The Washington Examiner (8/3, Leonardi, 448K), the Washington Times (8/3, Mordock, 492K), The Hill (8/3, Neidig, 2.98M), Politico (8/3, Gerstein, 4.29M), Reuters (8/3, Freifeld), and Bloomberg (8/3, Van Voris, 4.73M), among other news outlets, also cover Monday's court filings. Trump: Effor

RN- TVVi Nashville, TN (8/3, 24K), and WXIA-TVVI Atlanta (8/3, 100K). Monoclonal Antibodies Could Be "Next Big Advance" In Treatment. Reuters (8/3, Beasley) reports, "As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

rt." Politico <https://www.politico.com/news/2020/08/03/doj-fbi-review-of-surveillance-applications-finds-almost- all-errors-are-minor-391101> (8/3, Gerstein, 4.29M) reports, "A review by the Justice Department and FBI of their practices for seeking approval of intelligence-related surveillance found that

s://www.reuters.com/article/us-health-coronavirus-treatments-antibod/next-big-covid-19-treatment-may-be- manufactured-antibodies-idUSKBN2421DY> (8/3, Beasley) reports, "As the world awaits a COVID-I9 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

k for pro-Russian Ukrainian politicians." Politico <https://www.politico.com/news/2020/10/22/manafort-indictment-new-york-dismissal-431265> (10/22, Gerstein, 4.29M) also reports. Goldman To Pay Nearly $3B, Take Millions From Executives To Settle 1MDB Probe. The Wall Street Journal <https://wwvv.wsj.corn

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

ollars in offshore accounts and then lying to get loans after income dried up from his work for pro-Russian Ukrainian politicians." Politico (10/22, Gerstein, 4.29M) also reports. Goldman To Pay Nearly $3B, Take Millions From Executives To Settle 1MDB Probe. EFTA00148464 The Wall Street Journal (10/22

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

ollars in offshore accounts and then lying to get loans after income dried up from his work for pro-Russian Ukrainian politicians." Politico (10/22, Gerstein, 4.29M) also reports. Goldman To Pay Nearly $3B, Take Millions From Executives To Settle 1MDB Probe. The Wall Street Journal. (10/22, Hoffman, Subs

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-